SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-009178
Filing Date
2021-08-18
Accepted
2021-08-18 08:53:25
Documents
15
Period of Report
2021-08-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT azrx_8k.htm   iXBRL 8-K 20346
2 PRESS RELEASE azrx_ex991.htm EX-99.1 17861
  Complete submission text file 0001654954-21-009178.txt   171954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA azrx-20210818.xsd EX-101.SCH 5595
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20210818_cal.xml EX-101.CAL 890
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20210818_def.xml EX-101.DEF 2097
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20210818_lab.xml EX-101.LAB 15355
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20210818_pre.xml EX-101.PRE 9782
8 EXTRACTED XBRL INSTANCE DOCUMENT azrx_8k_htm.xml XML 3718
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 211185186
SIC: 2834 Pharmaceutical Preparations